We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $1.59B
1-Year Est. Return 855.46%
This Fund
S&P 500
This Quarter Est. Return
-9.03%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$408M
AUM Growth
+$79.8M
Cap. Flow
+$123M
Cap. Flow %
30.25%
Top 10 Hldgs %
70.96%
Holding
57
New
7
Increased
23
Reduced
8
Closed
15

Top Buys

Rank Stock Value
1
CAMP
CalAmp Corp.
CAMP
+$11.7M
2
EOLS icon
Evolus
EOLS
+$9.39M
3
DZSI
DZS Inc. Common Stock
DZSI
+$5.77M
4
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$3.01M
5
VCNX
Vaccinex, Inc. Common Stock
VCNX
+$2.74M

Top Sells

Rank Stock Value
1
LTRX icon
Lantronix
LTRX
+$5.39M
2
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.39M
3
PDFS icon
PDF Solutions
PDFS
+$4.05M
4
FOCL
EDAP TMS S.A.
FOCL
+$4.03M
5
OIIM
02Micro International
OIIM
+$3.95M

Sector Composition

Rank Sector Weight
1 Technology 36.38%
2 Healthcare 19.6%
3 Industrials 0.91%
4 Consumer Staples 0.45%
5 Financials 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYO icon
26
Myomo
MYO
$56.2M
$2.35M 0.58%
617,179
+15,250
+3% +$102K
NBSE
27
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$1.93M 0.47%
51,379
+1,365
+3% +$47.2K
IPWR icon
28
Ideal Power
IPWR
$74.2M
$1.88M 0.46%
213,368
+13,636
+7% +$122K
YTEN
29
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$1.82M 0.45%
14,320
+70
+0.5% +$7.23K
PDSB icon
30
PDS Biotechnology
PDSB
$43.4M
$1.75M 0.43%
282,609
-25,425
-8% -$158K
XFOR icon
31
X4 Pharmaceuticals
XFOR
$438M
$1.75M 0.43%
33,257
-15,546
-32% -$892K
ABEO icon
32
Abeona Therapeutics
ABEO
$413M
$1.58M 0.39%
201,004
+155,513
+342% +$1.07M
SLNO
33
DELISTED
Soleno Therapeutics
SLNO
$1.52M 0.37%
+453,333
New +$2.35M
RZLT icon
34
Rezolute
RZLT
$452M
$1.42M 0.35%
420,913
+155,732
+59% +$600K
CLRB icon
35
Cellectar Biosciences
CLRB
$20.5M
$1.26M 0.31%
6,123
+3,134
+105% +$549K
BLIN icon
36
Bridgeline Digital
BLIN
$14.4M
$1.26M 0.31%
660,521
-216,672
-25% -$420K
NLSPW
37
CALL
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$1.17M 0.29%
827,921
– –
CYTHW
38
CALL
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$935K 0.23%
294,931
– –
PCSA icon
39
Processa Pharmaceuticals
PCSA
$7.11M
$915K 0.22%
607
– –
HSDT icon
40
Solana Company
HSDT
$98.7M
$845K 0.21%
7
– –
AMPG icon
41
AmpliTech
AMPG
$147M
$461K 0.11%
+137,372
New +$449K
FKWL icon
42
Franklin Wireless
FKWL
$27M
$394K 0.1%
98,826
-291,174
-75% -$1.2M
BWAY
43
Brainsway
BWAY
$622M
– –
-415,694
Closed -$1.6M
CGTX icon
44
Cognition Therapeutics
CGTX
$96.7M
– –
-25,496
Closed -$161K
CNTX icon
45
Context Therapeutics
CNTX
$44.5M
– –
-762,721
Closed -$2.03M
DRMAW icon
46
CALL
Dermata Therapeutics Warrant
DRMAW
$12.4K
– –
-175,000
Closed -$305K
LTRX icon
47
Lantronix
LTRX
$266M
– –
-688,309
Closed -$5.39M
MIRM icon
48
Mirum Pharmaceuticals
MIRM
$6.14B
– –
-337,917
Closed -$5.39M
NMTC icon
49
NeuroOne Medical Technologies
NMTC
$14.2M
– –
-79,167
Closed -$921K
RNAZ icon
50
TransCode Therapeutics
RNAZ
$4.19M
– –
-2
Closed -$3.23M
1
2
3

Similar funds

VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

AIGH Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, AIGH Capital Management held 57 positions worth $408M, up 24% from $328M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

AIGH Capital Management deployed $123M of net new capital in Q1 2022, opening 7 new positions and adding to 23 existing holdings. Its largest new stake was CalAmp Corp.: 77,070 shares worth $13M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 56% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was PDF Solutions, an estimated $4.05M trimmed.

  • AIGH Capital Management's largest Q1 2022 buy was CalAmp Corp.: 77,070 shares worth $13M.
  • AIGH Capital Management added most to DZS Inc. Common Stock in Q1 2022, an estimated $5.77M increase.
  • AIGH Capital Management's biggest Q1 2022 reduction was PDF Solutions, cutting an estimated $4.05M.
  • AIGH Capital Management fully exited Mirum Pharmaceuticals in Q1 2022, selling an estimated $5.39M.
  • AIGH Capital Management's ten largest holdings make up 71% of its $408M portfolio in Q1 2022.
  • AIGH Capital Management opened 7 new positions and closed 15 in Q1 2022.
  • AIGH Capital Management's portfolio value rose 24% quarter-over-quarter to $408M.

Based on AIGH Capital Management's 13F filing for Q1 2022, filed 12 May 2022.